Log in

Effects of Surfactant and Polymer on Thermodynamic Solubility and Solution Stability of Carbamazepine–Cinnamic Acid Cocrystal

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This study was aimed at evaluating the solubility and solution stability of a cocrystal form of carbamazepine with cinnamic acid in the presence of sodium dodecyl sulfate (SDS) as surfactant and polyvinyl pyrrolidone K17 (PVP) as polymer in the aqueous medium. The solubilities of carbamazepine and cinnamic acid, as well as that of cocrystal, were evaluated in various media including phosphate buffer solution (PBS) (pH 6.8), SDS at 0.5 and 2% concentration, and PVP at 0.5, 1, and 2% concentration. Carbamazepine–cinnamic acid cocrystal was more soluble than carbamazepine alone in PBS. Solubility and solution stability of cocrystal were improved by PVP and SDS. At high SDS concentration (2%), solubility of cocrystal is less than carbamazepine because of preferential solubilization of the drug despite increase of solution stability. Thus, SDS and PVP significantly influence the solubility and solution stability of carbamazepine–cinnamic acid cocrystal, which should be taken into account in develo** cocrystal formulations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

References

  1. H. D. Williams, N. L. Trevaskis, S. A. Charman, et al., Pharmacol. Rev., 65, 315 – 499 (2013).

    Article  Google Scholar 

  2. N. Blagden, M. de Matas, P. T. Gavan, et al., Adv. Drug Deliv. Rev., 59, 617 – 630 (2007).

    Article  CAS  Google Scholar 

  3. A. Ainurofiq, R. Mauludin, D. Mudhakir, et al., Pharm. Sci., 26, 399 – 405 (2020).

    Article  CAS  Google Scholar 

  4. S. Aitipamula, R. Banerjee, A. K. Bansal, et al., Cryst. Growth Des., 12, 2147 – 2152 (2012).

    Article  CAS  Google Scholar 

  5. M. Karimi-Jafari, L. Padrela, G. M. Walker, et al., Cryst. Growth Des., 18, 6370 – 6387 (2018).

    Article  CAS  Google Scholar 

  6. D. D. Gadade and S. S. Pekamwar, Adv. Pharm. Bull., 6, 479 – 494 (2016).

    Article  CAS  Google Scholar 

  7. A. L. Grzesiak, M. Lang, K. Kim, et al., J. Pharm. Sci., 92, 2260 – 2271 (2003).

    Article  CAS  Google Scholar 

  8. N. Bolourtchian, A. Nokhodchi, and R. Dinarvand, Daru, 9, 12 – 22 (2001).

    CAS  Google Scholar 

  9. R. Shete, B. Thorat, and P. Amin, Pharm. Sci., 28, 459 – 469 (2022).

    CAS  Google Scholar 

  10. M. B. Hickey, M. L. Peterson, L. A. Scoppettuolo, et al., Eur. J. Pharm. Biopharm., 67, 112 – 119 (2007).

    Article  CAS  Google Scholar 

  11. S. L. Childs, N. Rodriguez-Hornedo, L. S. Reddy, et al., CrystEngComm, 10, 856 – 864 (2008).

    Article  CAS  Google Scholar 

  12. Q. Fu, Y. Han, Y. F. **e, et al., J. Mol. Struct., 1168, 145 – 152 (2018).

    Article  CAS  Google Scholar 

  13. S. Cherukuvada and T. N. Guru Row, Cryst. Growth Des., 14, 4187 – 4198 (2014).

    Article  CAS  Google Scholar 

  14. S. Kudo and H. Takiyama, J. Chem. Eng. Data, 63, 451 – 458 (2018).

    Article  CAS  Google Scholar 

  15. M. Ullah, I. Hussain, and C. C. Sun, Drug Dev. Ind. Pharm., 42, 969 – 976 (2016).

    Article  CAS  Google Scholar 

  16. F. Zhou, J. Zhou, H. Zhang, et al., J. Drug Deliv. Sci. Technol., 54, (2019).

  17. H. Yamashita and C. C. Sun, Pharm. Res., 35, 4 (2018).

    Article  Google Scholar 

  18. H. Yamashita and C. C. Sun, Pharm. Res., 36, 90 (2019).

    Article  Google Scholar 

  19. M. Maghsoodi and O. Narimanpour, Pharm. Sci., 26, 314 – 322 (2020).

    Article  CAS  Google Scholar 

  20. M. Maghsoodi and F. Shahi, Pharm. Sci., 25, 331 – 337 (2019).

    Article  Google Scholar 

  21. A. Alhalaweh, H. R. H. Ali, and S. P. Velaga, Cryst. Growth Des., 14, 643 – 648 (2014).

    Article  CAS  Google Scholar 

  22. M. Li, N. Qiao, and K. Wang, Pharmaceutics, 5, 508 – 524 (2013).

    Article  CAS  Google Scholar 

  23. M. Ullah, H. Ullah, G. Murtaza, et al., BioMed Res. Int., 2015 (2015).

  24. A. Avdeef, Eur. J. Pharm. Sci., 110, 2 – 18 (2017).

    Article  CAS  Google Scholar 

  25. F. Keramatnia, A. Shayanfar, and A. Jouyban, J. Pharm. Sci., 104, 2559 – 2565 (2015).

    Article  CAS  Google Scholar 

  26. H. G. Moradiya, M. T. Islam, S. Halsey, et al., CrystEngComm, 16, 3573 – 3583 (2014).

    Article  CAS  Google Scholar 

  27. A. Shayanfar, K. Asadpour-Zeynali, and A. Jouyban, J. Mol. Liq., 187, 171 – 176 (2013).

    Article  CAS  Google Scholar 

  28. M. S. Jasani, D. P. Kale, I. P. Singh, et al., Mol. Pharm., 16, 151 – 164 (2019).

    Article  CAS  Google Scholar 

  29. R. Thakuria, A. Delori, W. Jones, et al., Int. J. Pharm., 453, 101 – 125 (2013).

    Article  CAS  Google Scholar 

  30. K. Asadpour-Zeynali and M. Bastami, Spectrochim. Acta Part A Mol. Biomol. Spectrosc., 75, 589 – 597 (2010).

    Article  Google Scholar 

  31. K. Löbmann, R. Laitinen, H. Grohganz, et al., Mol. Pharm., 8, 1919 – 1928 (2011).

    Article  Google Scholar 

  32. A. Shayanfar and A. Jouyban, Powder Technol., 262, 242 – 248 (2014).

    Article  CAS  Google Scholar 

  33. J. P. Marcolongo and M. Mirenda, J. Chem. Educ., 88, 629 – 633 (2011).

    Article  CAS  Google Scholar 

  34. M. N. Alizadeh, A. Shayanfar, and A. Jouyban, J. Mol. Liq., 268, 410 – 414 (2018).

    Article  CAS  Google Scholar 

  35. P. Tran, Y. C. Pyo, D. H. Kim, et al., Pharmceutics, 11, (2019).

  36. H. A. Garekani, F. Sadeghi, and A. Ghazi, Drug Dev. Ind. Pharm., 29, 173 – 179 (2003).

    Article  CAS  Google Scholar 

  37. T. Loftsson, Int. J. Pharm., 531, 276 – 280 (2017).

    Article  CAS  Google Scholar 

  38. D. J. Good and R. H. Nair, Cryst. Growth Des., 9, 2252 – 2264 (2009).

    Article  CAS  Google Scholar 

  39. Z. Rahman, C. Agarabi, A. S. Zidan, et al., AAPS PharmSciTech, 12, 693 – 704 (2011).

    Article  CAS  Google Scholar 

  40. A. Shayanfar, S. Velaga, and A. Jouyban, Fluid Phase Equilibria, 363, 97 – 105 (2014).

    Article  CAS  Google Scholar 

  41. A. Alhalaweh, A. Sokolowski, N. Rodriguez-Hornedo, et al., Cryst. Growth Des., 11, 3923 – 3929 (2011).

    Article  CAS  Google Scholar 

  42. M. P. Lipert and N. Rodriguez-Hornedo, Mol. Pharm., 12, 3535 – 3546 (2015).

    Article  CAS  Google Scholar 

  43. A. Alvani, A. Jouyban, and A. Shayanfar, J. Mol. Liq., 281, 86 – 92 (2019).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali Shayanfar.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sabouri, S., Shayanfar, A. Effects of Surfactant and Polymer on Thermodynamic Solubility and Solution Stability of Carbamazepine–Cinnamic Acid Cocrystal. Pharm Chem J 56, 913–917 (2022). https://doi.org/10.1007/s11094-022-02726-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-022-02726-8

Keywords

Navigation